SEOM clinical guidelines in early-stage breast cancer 2015.
Breast cancer is a major public health problem. Despite remarkable advances in early diagnosis and treatment, one in three women may have metastases since diagnosis. Better understanding of prognostic and predictive factors allows us to select the most appropriate adjuvant therapy in each patient. In these guidelines, we summarize current evidence for the medical management of early-stage breast cancer.
Hospital Clínico San Carlos, Madrid, Spain. jagsaenz@yahoo.com.
J A
JA
Garcia-Saenz
Hospital Clínico Universitario, Valencia, Spain.
B
B
Bermejo
CIOCC Hospital Universitario Madrid Sanchinarro, Madrid, Spain.
L G
LG
Estevez
Complejo Asistencial Universitario de León, León, Spain.
A G
AG
Palomo
Hospital Universitari Quirón Dexeus, Barcelona, Spain.
X
X
Gonzalez-Farre
Hospital Universitari Germans Trias I Pujol de Badalona (ICO-Badalona), Barcelona, Spain.
M
M
Margeli
Hospital Durán i Reynals (ICO), Barcelona, Spain.
S
S
Pernas
Hospital del Mar - Parc de Salut Mar, Barcelona, Spain.
S
S
Servitja
Hospital Universitario de Salamanca-IBSAL, Salamanca, Spain.
C A
CA
Rodriguez
Hospital Universitario 12 de Octubre, Madrid, Spain.
E
E
Ciruelos
D001943:Breast Neoplasms / Q000175:diagnosis* / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008495:Medical Oncology; D009367:Neoplasm Staging; D017410:Practice Guidelines as Topic / Q000592:standards*; D012955:Societies, Medical
Adjuvant; Clinical guidelines; Early-stage breast cancer; Genomic platforms; Neoadjuvant